Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Fluconazole recalled?

Not under an active recall. Fluconazole was recalled 23 times in the past — all now closed. Most recent: Dec 27, 2022.

Most common reason: Sterility / contamination (7 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Fluconazole. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Fluconazole recalls on record

none so far in 2026; 23 on record, newest first
Class III · Low risk

Fluconazole Injection

Superpotent Drug: lots out of specification for elevated sodium chloride and fluconazole assay.

Terminated Wrong potency / content Renaissance Lakewood, LLC D-1033-2018
Class III · Low risk

Fluconazole Injection

Failed Stability Specifications: lot out of specification for elevated water vapor.

Terminated Stability / shelf life Renaissance Lakewood, LLC NDC 36000-002-10 D-1032-2018
Class III · Low risk

Fluconazole Injection

Superpotent Drug and Failed Stability Specifications: lot out of specification for elevated sodium chloride and elevated water vapor.

Terminated Wrong potency / content Renaissance Lakewood, LLC NDC 36000-003-06 D-1031-2018
Class II · Moderate risk

Fluconazole Injection

Labeling: Label mix-up - A complaint was received of one bag of Fluconazole Injection, Iso-Osmotic Sodium Chloride Diluent, USP, 2mg/mL, 50 mL found within the package of 100 mL bags.

Terminated Labeling / mix-up Renaissance Lakewood, LLC NDC 36000-002-10 D-0696-2018
Class II · Moderate risk

Fluconazole USP for prescription compounding

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Terminated Stability / shelf life American Pharmaceutical Ingredients LLC NDC 58597-8268-4 D-0492-2018
Class II · Moderate risk

Fluconazole Injection

Lack of assurance of sterility: customer complaints received for the presence of leaks.

Terminated Sterility / contamination Baxter Healthcare Corporation NDC 0338-6046-48 D-0788-2017
Class II · Moderate risk

Fluconazole Injection

Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

Terminated Sterility / contamination Claris Lifesciences Inc NDC 36000-003-06 D-0614-2017
Class II · Moderate risk

Fluconazole Injection

Lack of Assurance of Sterility: confirmed customer complaints of leaking bags.

Terminated Sterility / contamination Baxter Healthcare Corporation NDC 0338-6046-48 D-0206-2017
Class II · Moderate risk

Fluconazole Injection

Cross contamination with other products: metronidazole

Terminated Cross-contamination Sagent Pharmaceuticals Inc NDC 25021-0113-82 D-0780-2016
Class II · Moderate risk

Fluconazole Injection

Lack of Assurance of Sterility: Complaints of leaks due to an incomplete seal at the bag seam.

Terminated Sterility / contamination Baxter Healthcare Corp. NDC 0338-6046-48 D-0380-2015
Class II · Moderate risk

Fluconazole active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-677-2015
Class II · Moderate risk

Flucon/Gent*

Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.

Terminated Sterility / contamination Specialty Medicine Compounding Pharmacy D-420-2014
Class II · Moderate risk

Fluconazole

Labeling: Label Mixup: FLUCONAZOLE, Tablet, 200 mg may have potentially been mislabeled as one of the following drugs: VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree: AD65475_10, EXP: 5/28/2014; FLUCONAZOLE, Tablet, 100 mg, NDC 68462010230, Pedigree: W003064, EXP: 6/12/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-871-2014
Class II · Moderate risk

Fluconazole

Labeling:Label Mixup; FLUCONAZOLE, Tablet, 100 mg may be potentially mislabeled as PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, NDC 51991056601, Pedigree: W003086, EXP: 6/12/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-729-2014
Class II · Moderate risk

Fluconazole

Labeling:Label Mixup; FLUCONAZOLE, Tablet, 50 mg may be potentially mislabeled as FLUCONAZOLE, Tablet, 200 mg, NDC 00172541360, Pedigree: W003065, EXP: 6/12/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-728-2014